| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 09/20/2011 | US8022079 Methods of modulating PPAR gamma-type receptors |
| 09/20/2011 | US8022071 Nitrogenous heterocyclic compounds |
| 09/20/2011 | US8022062 6-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists |
| 09/20/2011 | US8022059 Indazole acrylic acid amide compound |
| 09/20/2011 | CA2645856C Pyrazoles as 11-beta-hsd-1 |
| 09/20/2011 | CA2583737C Compounds and compositions as protein kinase inhibitors |
| 09/20/2011 | CA2573346C Hepatitis c inhibitor peptide analogs |
| 09/20/2011 | CA2560523C Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and -1-oxoisoindolines and method of reducing tnf.alpha. levels |
| 09/20/2011 | CA2548668C Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication |
| 09/20/2011 | CA2541458C Pyrrole and pyrazole derivatives as potentiators of glutamate receptors |
| 09/20/2011 | CA2508923C Tetrahydroquinoline derivatives and their use as fsh receptor modulators |
| 09/20/2011 | CA2505033C Non-nucleoside reverse transcriptase inhibitors |
| 09/20/2011 | CA2503868C Sulfonamides, sulfamates and sulfamides as gamma-secretase inhibitors |
| 09/20/2011 | CA2476067C Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 09/20/2011 | CA2471943C .beta.-amyloid protein production-secretion inhibitors |
| 09/20/2011 | CA2462903C Beta-lactamyl vasopressin v1a antagonists |
| 09/20/2011 | CA2461812C 3-(arylamino)methylene-1,3-dihydro-2h-indol-2-ones as kinase inhibitors |
| 09/20/2011 | CA2454302C Method for controlling particular insect pests by applying anthranilamide compounds |
| 09/20/2011 | CA2443403C 5-membered heterocycles, preparation and use thereof as mao inhibitors and lipid peroxidation inhibitors, preparation thereof and use thereof as medicaments |
| 09/20/2011 | CA2440067C Quinolyl propyl piperidine derivatives, the preparation thereof and compositions containing same |
| 09/20/2011 | CA2439415C Cathepsin cysteine protease inhibitors |
| 09/20/2011 | CA2417904C Compounds acting as melanocortin receptor ligands |
| 09/15/2011 | WO2011112685A1 4,4-disubstituted piperidine derivatives useful as inhibitors of dipeptidyl peptidase-1 (dpp-1) |
| 09/15/2011 | WO2011112662A1 Piperidin-4-yl azetidine derivatives as jak1 inhibitors |
| 09/15/2011 | WO2011112191A1 Compounds for the treatment of hepatitis c |
| 09/15/2011 | WO2011111875A1 N-acyl cyclic amine derivative or pharmaceutically acceptable salt thereof |
| 09/15/2011 | WO2011111831A1 Compound containing pyridine ring and method for producing halogenated picoline derivative and tetrazolyloxime derivative |
| 09/15/2011 | WO2011111705A1 PROCESS FOR PREPARATION OF t-BUTOXYCARBONYLAMINE COMPOUNDS |
| 09/15/2011 | WO2011111053A1 Anhydrous lenalidomide form-i |
| 09/15/2011 | WO2011110876A1 Novel salts for the manufacture of pharmaceutical compositions |
| 09/15/2011 | WO2011110627A1 New cationic 7-amino-1,2,3,4- tetrahydroquinolines, deying composition comprising a cationic 7-amino-1,2,3,4-tetrahydroquinoline, method and uses. |
| 09/15/2011 | WO2011110613A1 Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5) |
| 09/15/2011 | WO2011110612A1 Inhibitors of protein kinases |
| 09/15/2011 | WO2011110511A1 Spect imaging agents of amyloid plaques |
| 09/15/2011 | WO2011110488A1 A novel pet imaging agent of amyloid plaques and its precursor |
| 09/15/2011 | WO2011110478A1 Dabigatran etexilate-containing pharmaceutical composition |
| 09/15/2011 | WO2011110199A1 A process for amidation of pyrrole carboxylate compounds |
| 09/15/2011 | WO2011021000A3 A process for the synthesis of naratriptan |
| 09/15/2011 | US20110224441 method for the preparation of dabigatran and its intermediates |
| 09/15/2011 | US20110224440 Processes for the preparation of 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione compounds |
| 09/15/2011 | US20110224439 Process for Manufacturing 5-Chloromethyl-2,3-Pyridine Dicarboxylic Acid Anhydrides |
| 09/15/2011 | US20110224433 Process for Manufacturing Substituted 3-pyridylmethyl Ammonium Bromides |
| 09/15/2011 | US20110224432 Heteroaryl compounds and uses thereof |
| 09/15/2011 | US20110224334 Near-infrared-ray absorbing material containing cyanine compound, and cyanine compound |
| 09/15/2011 | US20110224262 Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto |
| 09/15/2011 | US20110224258 Fungicidal heterocyclic compounds |
| 09/15/2011 | US20110224255 Tripeptidyl peptidase inhibitors |
| 09/15/2011 | US20110224254 Novel inhibitors |
| 09/15/2011 | US20110224253 Small-molecule inhibitors of the androgen receptor |
| 09/15/2011 | US20110224252 Novel imidazole derivatives |
| 09/15/2011 | US20110224250 Isoquinoline derivative, and pde inhibitor comprising same as active ingredient |
| 09/15/2011 | US20110224241 Isothiazole and pyrazole derivatives as fungicides |
| 09/15/2011 | US20110224230 Bicyclic dihydroimidazolone cgrp receptor antagonists |
| 09/15/2011 | US20110224225 Inhibitors of protein kinases |
| 09/15/2011 | US20110224210 Novel bis-amides as anti-malarial agents |
| 09/15/2011 | US20110224209 4,4-disubstituted piperidine derivatives useful as inhibitors of dipeptidyl peptidase-1 (dpp-1) |
| 09/15/2011 | US20110224208 Novel inhibitors of flavivirus replication |
| 09/15/2011 | US20110224207 Flavivirus inhibitors and methods for their use |
| 09/15/2011 | US20110224206 Triazole compounds that modulate hsp90 activity |
| 09/15/2011 | US20110224204 Di-substituted phenyl compounds |
| 09/15/2011 | US20110224203 Benzimidazole derivatives and their use as protein kinase inhibitors |
| 09/15/2011 | US20110224202 Pde10 inhibitors and related compositions and methods |
| 09/15/2011 | US20110224200 Therapeutic agent for chorioretinal degenerative disease containing pyridine-3-carbaldehyde 0-(piperidin-1-yl-propyl)-oxime derivative as active ingredient |
| 09/15/2011 | US20110224198 Aryl methyl benzoquinazolinine m1 receptor positive allosteric modulators |
| 09/15/2011 | US20110224189 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases |
| 09/15/2011 | US20110224185 Compounds and compositions as modulators of gpr119 activity |
| 09/15/2011 | US20110224137 Inhibitors of diacylglycerol acyltransferase |
| 09/15/2011 | US20110224136 Inhibitors of diacylglycerol acyltransferase |
| 09/15/2011 | US20110224124 pH Tuneable Amido-Gellant For Use In Consumer Product Compositions |
| 09/15/2011 | US20110224079 Spiroheterocyclic n-oxyamides as pesticides |
| 09/15/2011 | US20110223611 Lenalidomide and thalidomide immunoassays |
| 09/15/2011 | US20110223093 Ionic liquid systems for carbon dioxide and sulfur dioxide removal |
| 09/15/2011 | US20110219686 Plant growth regulator compositions and methods |
| 09/15/2011 | CA2793312A1 Anhydrous lenalidomide form-i |
| 09/15/2011 | CA2792539A1 N-acyl cyclic amine derivative or pharmaceutically acceptable salt thereof |
| 09/15/2011 | CA2792508A1 Piperidin-4-yl azetidine derivatives as jak1 inhibitors |
| 09/15/2011 | CA2792273A1 Dabigatran etexilate-containing pharmaceutical composition |
| 09/15/2011 | CA2789440A1 Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5) |
| 09/15/2011 | CA2789189A1 Inhibitors of protein kinases |
| 09/14/2011 | EP2364979A1 Pyrrole compounds |
| 09/14/2011 | EP2364974A1 N-(3-Phenylamino-quinoxalin-2-yl)-benzenesulfonamide derivatives as phosphatidylinositol 3-kinase inhibitors |
| 09/14/2011 | EP2364706A1 Pharmaceutical agent comprising quinolone compound |
| 09/14/2011 | EP2364312A2 Preparation of crystalline palonosetron hydrochloride |
| 09/14/2011 | EP2364306A1 Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors |
| 09/14/2011 | EP2364305A1 A crystalline form of lenalidomide and a process for its preparation |
| 09/14/2011 | EP2364302A2 Triazine, pyrimidine and pyridine analogs and their use as therapeutic agents and diagnostic probes |
| 09/14/2011 | EP2364298A1 Quinolone compound and pharmaceutical composition |
| 09/14/2011 | EP2364296A1 Pyrrolidines |
| 09/14/2011 | EP2364295A1 3-(benzylamino)-pyrrolidine derivatives and their use as nk-3 receptor antagonists |
| 09/14/2011 | EP2364087A1 7-hydroxy-benzoimidazole-4-yl-methanone derivatives and pbk inhibitors containing the same |
| 09/14/2011 | EP2231636B1 Pyrazole derivatives and use thereof as inhibitors of cyclin dependent kinases |
| 09/14/2011 | EP2225222B1 A quinoline derivative acting as a p2x7-receptor antagonist |
| 09/14/2011 | EP2201001B1 Novel imidazole derivatives |
| 09/14/2011 | EP2170864B1 Pyridone gpr119 g protein-coupled receptor agonists |
| 09/14/2011 | EP2139880B1 Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor |
| 09/14/2011 | EP2079731B1 Novel substituted piperidyl-propane-thiols |
| 09/14/2011 | EP2049501B1 Hydroxylated and methoxylated cyclopenta [d] pyrimidines as akt protein kinase inhibitors |
| 09/14/2011 | EP1911755B1 Benzoimidazole compound capable of inhibiting prostaglandin d synthetase |
| 09/14/2011 | EP1896421B1 Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase met |
| 09/14/2011 | EP1871374B1 2,3 substituted pyrazine sulfonamides as inhibitors of crth2 |